<p>Salem Investment Counselors Inc. 在最近向證券交易委員會提交的 13F 文件中表示，在第二季度將其在 CVS Health Corporation (NYSE:CVS - 免費報告) 的持股減少了 22.5%。該機構投資者在此期間出售了 14,135 股後，持有 48,751 股該藥房運營商的股票。Salem Investment Counselors Inc. 在 CVS Health 的持股在最近一個季度末價值 3,363,000 美元。</p>
<ul>
<li>MarketBeat 週迴顧 – 05/12 - 05/16</li>
</ul>
<p>其他一些大型投資者也最近調整了對該公司的持股。Essex Financial Services Inc. 在第一季度將其在 CVS Health 的持股增加了 0.8%。Essex Financial Services Inc. 目前持有 20,705 股該藥房運營商的股票，價值 1,403,000 美元，此前在上個季度購買了額外的 166 股。Hemington Wealth Management 在第一季度將其在 CVS Health 的持股增加了 33.7%。Hemington Wealth Management 目前持有 682 股該藥房運營商的股票，價值 46,000 美元，此前在上個季度購買了額外的 172 股。McIlrath &amp; Eck LLC 在第四季度將其在 CVS Health 的持股增加了 32.6%。McIlrath &amp; Eck LLC 目前持有 707 股該藥房運營商的股票，價值 32,000 美元，此前在上個季度購買了額外的 174 股。Sumitomo Life Insurance Co. 在第一季度將其在 CVS Health 的持股增加了 1.0%。Sumitomo Life Insurance Co. 目前持有 17,114 股該藥房運營商的股票，價值 1,159,000 美元，此前在上個季度購買了額外的 174 股。最後，Koshinski Asset Management Inc. 在第一季度將其在 CVS Health 的持股增加了 3.7%。Koshinski Asset Management Inc. 目前持有 4,930 股該藥房運營商的股票，價值 334,000 美元，此前在上個季度購買了額外的 178 股。當前 80.66% 的股票由機構投資者持有。</p>
<h2>CVS Health 股價上漲 0.4%</h2>
<p>CVS Health 股票週五開盤價為 75.00 美元。該股票的 50 日移動平均價格為 67.11 美元，200 日移動平均價格為 66.32 美元。CVS Health Corporation 的一年低點為 43.56 美元，一年高點為 75.55 美元。該公司的市值為 951.2 億美元，市盈率為 20.95，市盈增長比率為 0.82，貝塔值為 0.62。該公司的債務與股本比率為 0.74，流動比率為 0.80，速動比率為 0.62。</p>
<ul>
<li>現在是買入諾和諾德股票的好時機嗎？</li>
</ul>
<p>CVS Health (NYSE:CVS - 獲取免費報告) 最近於 7 月 31 日星期四公佈了季度財報。該藥房運營商報告每股收益為 1.81 美元，超出市場共識預期的 1.46 美元，超出 0.35 美元。CVS Health 的股本回報率為 10.51%，淨利潤率為 1.17%。該公司在本季度的收入為 989.2 億美元，而分析師預期為 948.7 億美元。去年同期，該公司每股收益為 1.83 美元。該公司的季度收入同比增長 8.4%。CVS Health 已將其 2025 財年的指引設定為每股收益 6.300-6.400。股票研究分析師預計 CVS Health Corporation 本年度將發佈每股收益 5.89 美元。</p>
<h2>CVS Health 宣佈分紅</h2>
<p>該公司最近還披露了季度分紅，該分紅於 8 月 1 日星期五支付。7 月 22 日的登記投資者獲得了 0.665 美元的分紅。該分紅的除息日為 7 月 22 日。這代表着年化分紅為 2.66 美元，收益率為 3.5%。CVS Health 的分紅支付比率 (DPR) 為 74.30%。</p>
<h2>分析師評級上調與下調</h2>
<ul>
<li>在業績疲軟和 CVS-諾和諾德合作後，艾利利是買入嗎？</li>
</ul>
<p>幾家券商對 CVS 進行了評估。Baird R W 在 8 月 14 日星期四的研究報告中將 CVS Health 的評級從 “持有” 上調至 “強力買入”。Jefferies Financial Group 在 6 月 30 日星期一的研究報告中將 CVS Health 的目標價從 74.00 美元上調至 80.00 美元，並給予該公司 “買入” 評級。UBS Group 在 8 月 18 日星期一的研究報告中將 CVS Health 的評級從 “中性” 上調至 “買入”，並將該公司的目標價從 67.00 美元上調至 79.00 美元。Bernstein Bank 在 7 月 16 日星期三的研究報告中將 CVS Health 的目標價從 78.00 美元下調至 72.00 美元，並對該股票設定了 “市場表現” 評級。最後，Cowen 在 8 月 4 日星期一的研究報告中重申了對 CVS Health 股票的 “買入” 評級。兩位研究分析師對該股票給予了強力買入評級，十九位給予了買入評級，三位對該股票給予了持有評級。根據 MarketBeat 的數據，該公司目前的共識評級為 “適度買入”，平均目標價為 77.89 美元。</p>
<p><strong>查看我們對 CVS 的最新分析</strong></p>
<h2>內部人士下注</h2>
<p>在相關消息中，董事 Anne A. Finucane 於 8 月 20 日星期三出售了 7,500 股 CVS Health 股票。該股票以平均價格 71.02 美元出售，總價值為 532,650.00 美元。出售完成後，該董事持有 22,156 股公司股票，價值約 1,573,519.12 美元。此交易代表其持股減少了 25.29%。該出售在向 SEC 的法律文件中披露，可以通過此超鏈接訪問。公司內部人士持有公司股票的 1.22%。</p>
<h2>關於 CVS Health</h2>
<p>(免費報告)</p>
<p>CVS Health Corporation 在美國提供健康解決方案。它通過醫療保險、健康服務和藥房與消費者健康三個部門運營。醫療保險部門提供傳統、自願和消費者導向的健康保險產品及相關服務。</p>
<h2>推薦故事</h2>
<ul>
<li>我們更看好的五隻股票，而不是 CVS Health</li>
<li>如何有效使用 MarketBeat 評級篩選器</li>
<li>乘着奢侈零售浪潮，這三隻高端品牌股票值得關注</li>
<li>低市盈率成長股：發掘投資機會</li>
<li>華爾街悄然看好這些中國科技巨頭</li>
<li>為什麼投資 5G？如何投資 5G 股票</li>
<li>Meta 的 6000 億美元美國投資：對股票是看跌還是看漲？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快速和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1000 美元在 CVS Health 嗎？</h2>
<p>在你考慮 CVS Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而 CVS Health 並不在名單上。</p>
<p>雖然 CVS Health 目前在分析師中有中性買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

西維斯

<p>根據最近的 SEC 文件，Salem Investment Counselors Inc.在第二季度減少了對 CVS Health Corporation 的持股比例，減持了 22.5%，出售了 14,135 股。出售後，該公司持有 48,751 股，估值約為 336 萬美元。其他機構投資者也調整了他們在 CVS 的持股。該股票開盤價為 75.00 美元，市值為 951.2 億美元，市盈率為 20.95。CVS 最近報告每股收益為 1.81 美元，超出預期，並宣佈季度股息為 0.665 美元</p>

<p>Salem Investment Counselors Inc. reduced its position in CVS Health Corporation (NYSE:CVS - Free Report) by 22.5% during the second quarter, according to the company in its most recent 13F filing with the Securities &amp; Exchange Commission. The institutional investor owned 48,751 shares of the pharmacy operator's stock after selling 14,135 shares during the period. Salem Investment Counselors Inc.'s holdings in CVS Health were worth $3,363,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Salem Investment Counselors Inc. 在最近向證券交易委員會提交的 13F 文件中表示，在第二季度將其在 CVS Health Corporation (NYSE:CVS - 免費報告) 的持股減少了 22.5%。該機構投資者在此期間出售了 14,135 股後，持有 48,751 股該藥房運營商的股票。Salem Investment Counselors Inc. 在 CVS Health 的持股在最近一個季度末價值 3,363,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 05/12 - 05/16</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 05/12 - 05/16</li>
</ul>
</div><p>A number of other large investors also recently modified their holdings of the company. Essex Financial Services Inc. lifted its holdings in shares of CVS Health by 0.8% in the 1st quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock worth $1,403,000 after purchasing an additional 166 shares in the last quarter. Hemington Wealth Management lifted its holdings in shares of CVS Health by 33.7% in the 1st quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator's stock worth $46,000 after purchasing an additional 172 shares in the last quarter. McIlrath &amp; Eck LLC lifted its holdings in shares of CVS Health by 32.6% in the 4th quarter. McIlrath &amp; Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 174 shares in the last quarter. Sumitomo Life Insurance Co. lifted its holdings in shares of CVS Health by 1.0% in the 1st quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator's stock worth $1,159,000 after purchasing an additional 174 shares in the last quarter. Finally, Koshinski Asset Management Inc. lifted its holdings in shares of CVS Health by 3.7% in the 1st quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator's stock worth $334,000 after purchasing an additional 178 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他一些大型投資者也最近調整了對該公司的持股。Essex Financial Services Inc. 在第一季度將其在 CVS Health 的持股增加了 0.8%。Essex Financial Services Inc. 目前持有 20,705 股該藥房運營商的股票，價值 1,403,000 美元，此前在上個季度購買了額外的 166 股。Hemington Wealth Management 在第一季度將其在 CVS Health 的持股增加了 33.7%。Hemington Wealth Management 目前持有 682 股該藥房運營商的股票，價值 46,000 美元，此前在上個季度購買了額外的 172 股。McIlrath &amp; Eck LLC 在第四季度將其在 CVS Health 的持股增加了 32.6%。McIlrath &amp; Eck LLC 目前持有 707 股該藥房運營商的股票，價值 32,000 美元，此前在上個季度購買了額外的 174 股。Sumitomo Life Insurance Co. 在第一季度將其在 CVS Health 的持股增加了 1.0%。Sumitomo Life Insurance Co. 目前持有 17,114 股該藥房運營商的股票，價值 1,159,000 美元，此前在上個季度購買了額外的 174 股。最後，Koshinski Asset Management Inc. 在第一季度將其在 CVS Health 的持股增加了 3.7%。Koshinski Asset Management Inc. 目前持有 4,930 股該藥房運營商的股票，價值 334,000 美元，此前在上個季度購買了額外的 178 股。當前 80.66% 的股票由機構投資者持有。</p>
</div><h2>CVS Health Trading Up 0.4%</h2>
<div class="lb-trans"><h2>CVS Health 股價上漲 0.4%</h2>
</div><p>Shares of CVS Health stock opened at $75.00 on Friday. The stock has a fifty day moving average price of $67.11 and a 200-day moving average price of $66.32. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $75.55. The firm has a market cap of $95.12 billion, a PE ratio of 20.95, a P/E/G ratio of 0.82 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62.</p>
<div class="lb-trans"><p>CVS Health 股票週五開盤價為 75.00 美元。該股票的 50 日移動平均價格為 67.11 美元，200 日移動平均價格為 66.32 美元。CVS Health Corporation 的一年低點為 43.56 美元，一年高點為 75.55 美元。該公司的市值為 951.2 億美元，市盈率為 20.95，市盈增長比率為 0.82，貝塔值為 0.62。該公司的債務與股本比率為 0.74，流動比率為 0.80，速動比率為 0.62。</p>
</div><ul>
<li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>現在是買入諾和諾德股票的好時機嗎？</li>
</ul>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same quarter last year, the firm posted $1.83 EPS. The firm's revenue for the quarter was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.</p>
<div class="lb-trans"><p>CVS Health (NYSE:CVS - 獲取免費報告) 最近於 7 月 31 日星期四公佈了季度財報。該藥房運營商報告每股收益為 1.81 美元，超出市場共識預期的 1.46 美元，超出 0.35 美元。CVS Health 的股本回報率為 10.51%，淨利潤率為 1.17%。該公司在本季度的收入為 989.2 億美元，而分析師預期為 948.7 億美元。去年同期，該公司每股收益為 1.83 美元。該公司的季度收入同比增長 8.4%。CVS Health 已將其 2025 財年的指引設定為每股收益 6.300-6.400。股票研究分析師預計 CVS Health Corporation 本年度將發佈每股收益 5.89 美元。</p>
</div><h2>CVS Health Announces Dividend</h2>
<div class="lb-trans"><h2>CVS Health 宣佈分紅</h2>
</div><p>The company also recently disclosed a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were issued a $0.665 dividend. The ex-dividend date of this dividend was Tuesday, July 22nd. This represents a $2.66 annualized dividend and a yield of 3.5%. CVS Health's dividend payout ratio (DPR) is 74.30%.</p>
<div class="lb-trans"><p>該公司最近還披露了季度分紅，該分紅於 8 月 1 日星期五支付。7 月 22 日的登記投資者獲得了 0.665 美元的分紅。該分紅的除息日為 7 月 22 日。這代表着年化分紅為 2.66 美元，收益率為 3.5%。CVS Health 的分紅支付比率 (DPR) 為 74.30%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級上調與下調</h2>
</div><ul>
<li>Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?</li>
</ul>
<div class="lb-trans"><ul>
<li>在業績疲軟和 CVS-諾和諾德合作後，艾利利是買入嗎？</li>
</ul>
</div><p>Several brokerages have weighed in on CVS. Baird R W upgraded CVS Health from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Thursday, August 14th. Jefferies Financial Group raised their price objective on CVS Health from $74.00 to $80.00 and gave the company a &#34;buy&#34; rating in a research note on Monday, June 30th. UBS Group upgraded CVS Health from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and raised their price objective for the company from $67.00 to $79.00 in a research note on Monday, August 18th. Bernstein Bank dropped their price objective on CVS Health from $78.00 to $72.00 and set a &#34;market perform&#34; rating on the stock in a research note on Wednesday, July 16th. Finally, Cowen restated a &#34;buy&#34; rating on shares of CVS Health in a research note on Monday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $77.89.</p>
<div class="lb-trans"><p>幾家券商對 CVS 進行了評估。Baird R W 在 8 月 14 日星期四的研究報告中將 CVS Health 的評級從 “持有” 上調至 “強力買入”。Jefferies Financial Group 在 6 月 30 日星期一的研究報告中將 CVS Health 的目標價從 74.00 美元上調至 80.00 美元，並給予該公司 “買入” 評級。UBS Group 在 8 月 18 日星期一的研究報告中將 CVS Health 的評級從 “中性” 上調至 “買入”，並將該公司的目標價從 67.00 美元上調至 79.00 美元。Bernstein Bank 在 7 月 16 日星期三的研究報告中將 CVS Health 的目標價從 78.00 美元下調至 72.00 美元，並對該股票設定了 “市場表現” 評級。最後，Cowen 在 8 月 4 日星期一的研究報告中重申了對 CVS Health 股票的 “買入” 評級。兩位研究分析師對該股票給予了強力買入評級，十九位給予了買入評級，三位對該股票給予了持有評級。根據 MarketBeat 的數據，該公司目前的共識評級為 “適度買入”，平均目標價為 77.89 美元。</p>
</div><p><strong>View Our Latest Analysis on CVS</strong></p>
<div class="lb-trans"><p><strong>查看我們對 CVS 的最新分析</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><p>In related news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director owned 22,156 shares of the company's stock, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 1.22% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，董事 Anne A. Finucane 於 8 月 20 日星期三出售了 7,500 股 CVS Health 股票。該股票以平均價格 71.02 美元出售，總價值為 532,650.00 美元。出售完成後，該董事持有 22,156 股公司股票，價值約 1,573,519.12 美元。此交易代表其持股減少了 25.29%。該出售在向 SEC 的法律文件中披露，可以通過此超鏈接訪問。公司內部人士持有公司股票的 1.22%。</p>
</div><h2>About CVS Health</h2>
<div class="lb-trans"><h2>關於 CVS Health</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy &amp; Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.</p>
<div class="lb-trans"><p>CVS Health Corporation 在美國提供健康解決方案。它通過醫療保險、健康服務和藥房與消費者健康三個部門運營。醫療保險部門提供傳統、自願和消費者導向的健康保險產品及相關服務。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>How to Effectively Use the MarketBeat Ratings Screener</li>
<li>Ride the Luxury Retail Wave with These 3 High-End Brand Stocks</li>
<li>Low PE Growth Stocks: Unlocking Investment Opportunities</li>
<li>Wall Street Quietly Bets Big on These Chinese Tech Giants</li>
<li>Why Invest in 5G? How to Invest in 5G Stocks</li>
<li>Meta's $600B U.S. Investment: Bearish or Bullish for Shares?</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而不是 CVS Health</li>
<li>如何有效使用 MarketBeat 評級篩選器</li>
<li>乘着奢侈零售浪潮，這三隻高端品牌股票值得關注</li>
<li>低市盈率成長股：發掘投資機會</li>
<li>華爾街悄然看好這些中國科技巨頭</li>
<li>為什麼投資 5G？如何投資 5G 股票</li>
<li>Meta 的 6000 億美元美國投資：對股票是看跌還是看漲？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快速和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 CVS Health 嗎？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 CVS Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而 CVS Health 並不在名單上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 CVS Health 目前在分析師中有中性買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Salem Investment Counselors Inc. 出售了 14,135 股西維斯的股票